UB Paderborn / Katalog / Suche / in CDI

How do doctors choose treatment for older gynecological cancer patients? A Japanese Gynecologic Oncology Group survey of gynecologic oncologists

International journal of clinical oncology, 2020-04, Vol.25 (4), p.741-745

2020

Volltextzugriff (PDF)

Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey

Journal of Gynecologic Oncology, 2023, 34(1), , pp.1-14

2023

Volltextzugriff (PDF)

Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer

The journal of obstetrics and gynaecology research, 2019-07, Vol.45 (7), p.1371-1375

2019

Volltextzugriff (PDF)

Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

Chinese journal of cancer research, 2020-04, Vol.32 (2), p.218-227

2020

Volltextzugriff (PDF)

Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Gynecologic oncology, 2013-01, Vol.128 (1), p.22-27

2013

Volltextzugriff (PDF)

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)

World journal of surgical oncology, 2017-07, Vol.15 (1), p.132-132, Article 132

2017

Volltextzugriff (PDF)

A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial)

Gynecologic oncology, 2011-02, Vol.120 (2), p.193-197

2011

Volltextzugriff (PDF)

A Phase I/II Study of Docetaxel and Gemcitabine Combination for Chemotherapy-resistant Ovarian Cancer

Anticancer research, 2009-05, Vol.29 (5), p.1521-1526

2009

Volltextzugriff (PDF)

A post-hoc study of relative dose intensity in elderly patients with advanced ovarian cancer (JGOG3016-A3)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18053-e18053

2020

Volltextzugriff (PDF)

Comparison of older and younger patients with ovarian cancer: A post hoc study (JGOG3016‐A3) of the treatment strength and prognostic outcomes of conventional or dose‐dense chemotherapy

The journal of obstetrics and gynaecology research, 2023-05, Vol.49 (5), p.1400-1411

2023

Volltextzugriff (PDF)

Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey

Journal of gynecologic oncology, 2023-01, Vol.34 (1), p.1-14

2023

Volltextzugriff (PDF)

Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary

The journal of obstetrics and gynaecology research, 2002-06, Vol.28 (3), p.166-171

2002

Volltextzugriff (PDF)

A retrospective analysis of lymph node status in advanced ovarian, fallopian, and peritoneal cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17074-e17074

2017

Volltextzugriff (PDF)

Postoperative cytological findings from the use of the I ntegran microfibrillar collagen hemostatic matrix in conization

Diagnostic cytopathology, 2018-07, Vol.46 (7), p.624-626

2018

Volltextzugriff (PDF)

Cervical adenocarcinoma with stromal micropapillary pattern

Diagnostic cytopathology, 2016-02, Vol.44 (2), p.133-136

2016

Volltextzugriff (PDF)

Protocol for a Prospective Cohort Study to Evaluate Changes in Sexuality in Patients With Primary Cervical Cancer Using Patient-Reported Outcomes (JGOG9004, SARAH Study), and Our Approaches to Solving the Unmet Needs of Patients With Gynecological Cancer

Journal of clinical gynecology and obstetrics, 2023-08, Vol.12 (2), p.59-64

2023

Volltextzugriff (PDF)

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

Gynecologic oncology, 2012-09, Vol.126 (3), p.341-345

2012

Volltextzugriff (PDF)

Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330)

Anticancer research, 2013-03, Vol.33 (3), p.1073-1079

2013

Volltextzugriff (PDF)

Mental mood of gynecologic cancer patients assessed by distress and impact thermometer (DIT; a two-item, self-report questionnaire) and hospital anxiety and depression scale (HADS; a 14-item, self-report questionnaire) during the initial treatment in the first 6 months: KCOG-G1103 study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9568-9568

2014

Volltextzugriff (PDF)

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting for gynecological cancer: KCOG G-1301 phase II trial

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS9639-TPS9639

2015

Volltextzugriff (PDF)

Phase 1/2 study of concurrent chemo-radiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

Chinese journal of cancer research, 2020, Vol.32 (2), p.218-227

2020

Volltextzugriff (PDF)

A case of mesodermal mixed tumor (MMT) of the ovary-cytological and immunohistochemical study

The Journal of the Japanese Society of Clinical Cytology, 1994, Vol.33(3), pp.568-574

1994

Volltextzugriff (PDF)

A Dose-finding Study of Nedaplatin and Cyclophosphamide for Patients with Gynecological Malignancies

Japanese journal of clinical oncology, 1999-06, Vol.29 (6), p.299-302

1999

Volltextzugriff (PDF)

Ascitic fluid and imprint cytology of mixed germ cell tumor of the ovary

Acta cytologica, 2002-01, Vol.46 (1), p.65

2002

Volltextzugriff (PDF)

Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer

Oncology reports, 2001-01, Vol.8 (1), p.27

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

How do doctors choose treatment for older gynecological cancer patients? A Japanese Gynecologic Oncology Group survey of gynecologic oncologists

Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey

Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer

Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)

A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial)

A Phase I/II Study of Docetaxel and Gemcitabine Combination for Chemotherapy-resistant Ovarian Cancer

A post-hoc study of relative dose intensity in elderly patients with advanced ovarian cancer (JGOG3016-A3)

Comparison of older and younger patients with ovarian cancer: A post hoc study (JGOG3016‐A3) of the treatment strength and prognostic outcomes of conventional or dose‐dense chemotherapy

Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey

Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary

A retrospective analysis of lymph node status in advanced ovarian, fallopian, and peritoneal cancer

Postoperative cytological findings from the use of the I ntegran microfibrillar collagen hemostatic matrix in conization

Cervical adenocarcinoma with stromal micropapillary pattern

Protocol for a Prospective Cohort Study to Evaluate Changes in Sexuality in Patients With Primary Cervical Cancer Using Patient-Reported Outcomes (JGOG9004, SARAH Study), and Our Approaches to Solving the Unmet Needs of Patients With Gynecological Cancer

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study

Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330)

Mental mood of gynecologic cancer patients assessed by distress and impact thermometer (DIT; a two-item, self-report questionnaire) and hospital anxiety and depression scale (HADS; a 14-item, self-report questionnaire) during the initial treatment in the first 6 months: KCOG-G1103 study

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting for gynecological cancer: KCOG G-1301 phase II trial

Phase 1/2 study of concurrent chemo-radiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

A case of mesodermal mixed tumor (MMT) of the ovary-cytological and immunohistochemical study

A Dose-finding Study of Nedaplatin and Cyclophosphamide for Patients with Gynecological Malignancies

Ascitic fluid and imprint cytology of mixed germ cell tumor of the ovary

Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer

Suchergebnisse filtern